Activation of α7nAChR by nicotine reduced the Th17 response in CD4+T lymphocytes

Immunological Investigations

Volumn 43, Issue 7, 2014, Pages 667-674

  Liu, Zhigang ^a   Han, Bo ^a   Li, Peijie ^a   Wang, Zie ^a   Fan, Qing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Interleukin 17; Lymphocytes; Nicotinic acetylcholine receptor 7

Indexed keywords

ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; FICOLL; INTERLEUKIN 17; NICOTINE; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH17 CELL; DRUG EFFECTS; IMMUNOLOGY; MONONUCLEAR CELL; YOUNG ADULT;

ADULT; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; NICOTINE; YOUNG ADULT;

EID: 84907031291     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2014.914532     Document Type: Article

References (25)

1. De Rosa MJ, Esandi Mdel C, Garelli A, et al. (2005). Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol, 160(1-2), 154-61.
2. Filippini P, Cesario A, Fini M, et al. (2012). The Yin and Yang of non-neuronal alpha7-nicotinic receptors in inflammation and autoimmunity. Curr Drug Targets, 13, 644-55.
3. Fujii T, Takada-Takatori Y, Kawashima K. (2012). Regulatory mechanisms of acetylcholine synthesis and release by T cells. Life Sci, 91, 981-5.
4. Fujii T, Watanabe Y, Inoue T, Kawashima K. (2003a). Up-regulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T-and B-lymphocytes during immunological responses. Neurochem Res, 28, 423-9.
5. Fujii T, Watanabe Y, Fujimoto K, Kawashima K. (2003b). Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation. Biog Amine, 17, 373-86.
6. Fujii YX, Fujigaya H, Moriwaki Y, et al. (2007). Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J Neuroimmunol, 189(1-2), 69-74.
7. Hagforsen E, Einarsson A, Aronsson F, et al. (2000). The distribution of choline acetyltransferase-and acetylcholinesterase-like immunoreactivity in the palmar skin of patients with palmoplantar pustulosis. Br J Dermatol, 142, 234-42.
8. Ju JH, Heo YJ, Cho ML, et al. (2012). Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells. Arthritis Rheum, 64, 3543-52.
9. Kawashima K, Fujii T, Moriwaki Y, et al. (2012). Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function. Ann NY Acad Sci, 1261, 7-17.
10. Koval L, Lykhmus O, Zhmak M, et al. (2011). Differential involvement of alpha4 beta2, alpha7 and alpha9, alpha10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro. Int J Biochem Cell Biol, 43, 516-24.
11. Lim J-Y, Cho B-S, Min C-K, et al. (2014). Fluctuations in pathogenic CD4+T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol Invest, 43, 41-53.
12. Miossec P, Korn T, Kuchroo VK. (2009). Interleukin-17 and type 17 helper T cells. N Engl J Med, 361, 888-98.
13. Nizri E, Hamra-Amitay Y, Sicsic C, et al. (2006). Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors. Neuropharmacology, 50(5), 540-7.
14. Nizri E, Irony-Tur-Sinai M, Faranesh N, et al. (2008). Suppression of neuroinflammation and immunomodulation by the acetylcholinester-ase inhibitor rivastigmine. J Neuroimmunol, 203, 12-22.
15. Qian J, Galitovskiy V, Chernyavsky AI, et al. (2011). Plasticity of the murine spleen Tcell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun, 12, 222-30.
16. Rinner I, Kawashima K, Schauenstein K. (1998). Rat lymphocytes produce and secrete acetylcho-line in dependence of differentiation and activation. J Neuroimmunol, 81, 31-7.
17. Rosas-Ballina M, Olofsson PS, Ochani M, et al. (2011). Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science, 334, 98-101.
18. Sato KZ, Fujii T, Watanabe Y, et al. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett, 266, 17-20.
19. Shytle RD, Mori T, Townsend K, et al. (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem, 89, 337-43.
20. Skok MV, Kalashnik EN, Koval L, et al. (2003). Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol Pharmacol, 64, 885-9.
21. Takahashi HK, Iwagaki H, Hamano R, et al. (2007). The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. Euro J Pharmacol, 559, 69-74.
22. Wang H, Yu M, Ochani M, et al. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 421, 384-8.
23. Wang Y, Pereira EF, Maus AD, et al. (2001). Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol, 60, 1201-9.
24. Wessler I, Kirkpatrick CJ. (2008). Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Brit J Pharmacol, 154, 1558-71.
25. Wessler I, Kirkpatrick CJ, Racke K. (1998). Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans. Pharmacol Therapeut, 77, 59-79.